Kentucky - QUILS™ Implementation | MicrobiomeTrials← Back to trialsNCT07639255
Kentucky - QUILS™ Implementation
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2025-04-01Est. Completion: 2027-06-01
Enrollment target: 330 participants Locations- University of Mississippi Medical Center, Jackson, Mississippi, United States
Other microbiome trials you might be interested in
MelanomaLi-Fraumeni SyndromePulmonary BlastomaChordomaCongenital Bone Marrow Failure SyndromesCostello SyndromeFanconi AnemiaCFC Syndrome (CFCS)Legius SyndromeRASopathies
Background:
Clinical Genetics Branch (CGB) researchers study individuals and populations at high genetic risk of cancer…
Rockville, United StatesEst. completion Jan 1, 2035
Non-Small Cell Lung CancerNon-Small Cell Lung CarcinomaCarcinoma, Non-Small-Cell LungCarcinomas
Background:
Surgery is the primary treatment for non-small cell lung cancer (NSCLC) that is diagnosed in its earlier st…
Bethesda, United StatesCompleted Dec 30, 2033